mediaroom-news

Media Office

pressoffice@spmsd.com
Phone:
+33 4 37 28 40 41

Media Room

Archive

In News

Sanofi Pasteur MSD recognized as one of the Best Places to Work in Spain

Spanish affiliate named one of the top companies with 50 – 100 employees

 Lyon, May 12th, 2014 – We’re pleased to share the news that on May 7th, our Spanish affiliate was recognized by the Great Place to Work organisation as one of the 50 Best Places to Work in Spain in 2014.

Our team was recognized among 11 other pharmaceutical companies on the list and captured a spot among the top 8 best companies with 50 – 100 employees.

“I believe our business model provides a key strategic advantage.  We are able to work closely all together, proactively build trust and pride amongst each other,” notes Ricardo Brage, Vice President of Sanofi Pasteur MSD and Managing Director of the company in Spain.  “It contributes to a strongly positive work environment here.”

“This award publicly confirms a trend we’ve seen with our Spanish team over the last several years: strong performance clearly achieved through exceptional teamwork,” adds Jean-Paul Kress, President of Sanofi Pasteur MSD.

Sanofi Pasteur MSD joins the Great Place to Work organisation in congratulating our team and all of the award winners in 2014.  We’re proud to represent vaccine companies in this leading group of organisations across Europe.

For more information on the Great Place to Work organisation, visit http://www.greatplacetowork.com/index.php

# # # 

About Sanofi Pasteur MSD www.spmsd.com

Sanofi Pasteur MSD is a European joint venture formed between Sanofi Pasteur (the vaccine division of Sanofi) and Merck (known as MSD outside the United States and Canada). Combining innovation and expertise, Sanofi Pasteur MSD is the only European pharmaceutical company dedicated exclusively to the distribution of vaccines. Sanofi Pasteur MSD makes use of the combined expertise resulting from Sanofi Pasteur and Merck’s research to focus on the development of new vaccines in Europe in order to produce the most effective, most acceptable and better tolerated vaccines.

– END –

For further information please contact:

Sanofi Pasteur MSD Corporate
Sylvia Martin-Jarrand
Tel : +33 4 37 28 40 55
Mob : +33 6 74 85 19 63
smartin-jarrand@spmsd.com

Sanofi Pasteur MSD Spain
Cristina Justo
Tel : + 34 91 371 78 04
cjusto@spmsd.com

Download a copy of the the full release here.

 

In News

Sanofi Pasteur MSD welcomes European Immunization Week 2014

European vaccine leader hosts events across the region to help raise awareness of immunization throughout life

Lyon, France – April 22, 2014 – Sanofi Pasteur MSD welcomes the World Health Organization’s European Immunization Week 2014 (EIW 2014) with a series of awareness-raising events across the region, taking place between April 22nd and 26th. Sanofi Pasteur MSD, the European leader for vaccines in Europe, has joined forces with NGOs, health care professionals to help raise awareness of the important benefits of full vaccination throughout life.

The goal of European Immunization Week is to increase vaccination coverage. Each day of the week will focus on lifelong immunization from early childhood to adolescence through to adulthood and old age.

At Sanofi Pasteur MSD, many subsidiaries will roll-out external engagement initiatives to support EIW 2014 such as: a public awareness campaign involving major basketball clubs in Spain and a UNICEF-partnered media. An informational event in the UK for the public in partnership with top university experts and local lawmakers. A parent-focused breakfast in Portugal with opinion-leading bloggers and national pediatric health experts.

At Sanofi Pasteur MSD headquarters, an internal campaign will involve all employees in supporting the European Immunization Week 2014.

Vaccines are unquestionably one of the most cost-effective public health measures available”, says Dr Jean-Paul Kress, President of Sanofi Pasteur MSD. “Wide-spread vaccination has eradicated smallpox and made Europe polio-free”.

Groundbreaking innovative science has continued to offer us new vaccines that extend protection against infectious diseases in childhood and well beyond“, notes also Dr Kress. Raising awareness – thanks to European Immunization Week is an important step towards reaching European immunization goals,” concludes Dr Kress.

For further information about events on a national level across Europe, visit the WHO’s dedicated campaign website: http://eiw.euro.who.int.  Activities are timed to coincide with World-wide events as part of World Immunization Week, also led by the WHO: http://www.who.int/campaigns/immunization-week/2014/en/ .

# # #

About Sanofi Pasteur MSD www.spmsd.com

Sanofi Pasteur MSD is a European joint venture formed between Sanofi Pasteur (the vaccine division of Sanofi) and Merck (known as MSD outside the United States and Canada). Combining innovation and expertise, Sanofi Pasteur MSD is the only European pharmaceutical company dedicated exclusively to the distribution of vaccines. Sanofi Pasteur MSD makes use of the combined expertise resulting from Sanofi Pasteur and Merck’s research to focus on the development of new vaccines in Europe in order to produce the most effective, most acceptable and better tolerated vaccines.

About European Immunization Week eiw.euro.who.int

European Immunization Week (EIW) promotes the core message that the immunization of every child is vital to prevent diseases and protect life. The goal is to increase vaccination coverage by raising awareness of the importance of immunization.  “Immunization for life” will be the theme of EIW 2014, to take place from 22 to 26 April. Activities in the Region will focus on all age groups – reminding parents to vaccinate their children but also underlining the importance of maintaining personal protection from preventable diseases throughout the life course.

- END -

 Download the full release here

For further information please contact:

Sanofi Pasteur MSD
Sylvia Martin-Jarrand
Tel : +33 4 37 28 40 55
Mob : +33 6 33 46 13 65
smartin-jarrand@spmsd.com

In News

Sanofi Pasteur MSD Moves into new European Headquarters in Lyon, France

March 17, 2014, Lyon, France.

On March 17, 2014, Sanofi Pasteur MSD (SPMSD), the only company exclusively dedicated to vaccines for Europe, moved its corporate headquarters to the new “Ambre” building in Lyon, France, located at 162 avenue Jean-Jaures, in the city’s 7th arrondissement.

The move comes during a milestone year for the company, which marks its 20th anniversary in 2014, as well.  SPMSD was created in 1994 out of a joint venture between Sanofi Pasteur, the vaccine division of Sanofi, and Merck, known as MSD outside North America.

The move strongly supports the company’s development.  Previously spread across three different buildings, all corporate teams will now work under one roof.  Corporate teams focus on pan-European activities and serve as the central nervous system for 19 national affiliates operating across Europe.

SPMSD professionals work in close networks in order to develop and deliver vaccines that meet the unique needs of European populations.  Ambre’s configurations and state-of-the-art workplace tools will further facilitate new levels of collaboration amongst the teams.

“We’re thrilled to start leveraging everything that these new offices have to offer,” notes Jean-Paul Kress, President of Sanofi Pasteur MSD.  “The space will further facilitate our ability to seamlessly work together across functions and geographies in support of our unique European-focused mission.”

The new location is just a few kilometers from the company’s original home at 8 rue Jonas Salk.  It keeps the teams squarely at the heart of Lyon’s Gerland “Biopole” district, in close proximity to external collaborations essential to continued long-term development in France’s leading bio-scientific industries.

About Sanofi Pasteur MSD

Sanofi Pasteur MSD is a joint venture between Sanofi Pasteur, the vaccine division of Sanofi, and Merck, known as MSD outside the USA and Canada. Combining innovation and expertise, Sanofi Pasteur MSD is the only company in Europe dedicated exclusively to vaccines. Sanofi Pasteur MSD is able to draw on the research expertise of Sanofi Pasteur and Merck to focus on the development of new vaccines for Europe to improve the acceptability, efficacy and tolerability of vaccination.

Download the full announcement here